Absence of PMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A

被引：0
|
作者：
Warner, LE
Roa, BB
Lupski, JR
机构：
[1] BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030
[2] BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030
[3] BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030
来源：
HUMAN MUTATION | 1996年 / 8卷 / 04期
关键词：
D O I：
10.1002/(SICI)1098-1004(1996)8:4<362::AID-HUMU10>3.0.CO;2-0
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：362 / 365
页数：4
相关论文
共 50 条
  • [31] Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1A neuropathy
    Roa, BB
    Greenberg, F
    Gunaratne, P
    Sauer, CM
    Lubinsky, MS
    Kozma, C
    Meck, JM
    Magenis, RE
    Shaffer, LG
    Lupski, JR
    HUMAN GENETICS, 1996, 97 (05) : 642 - 649
  • [32] THE DIAGNOSIS AND PREVALENCE OF DUPLICATION OF THE CMT1A LOCUS IN CHARCOT-MARIE-TOOTH TYPE-I DISEASE
    BORT, S
    SEVILLA, T
    VILCHEZ, JJ
    PRIETO, F
    PALAU, F
    MEDICINA CLINICA, 1995, 104 (17): : 648 - 652
  • [33] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
    van Paassen, Barbara W.
    van der Kooi, Anneke J.
    van Spaendonck-Zwarts, Karin Y.
    Verhamme, Camiel
    Baas, Frank
    de Visser, Marianne
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [34] Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease
    Nobbio, L
    Vigo, T
    Abbruzzese, M
    Levi, G
    Brancolini, C
    Mantero, S
    Grandis, M
    Benedetti, L
    Mancardi, G
    Schenone, A
    NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 263 - 273
  • [35] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
    Barbara W van Paassen
    Anneke J van der Kooi
    Karin Y van Spaendonck-Zwarts
    Camiel Verhamme
    Frank Baas
    Marianne de Visser
    Orphanet Journal of Rare Diseases, 9
  • [36] Genotype-phenotype correlation of Charcot-Marie-Tooth type 1E patients with PMP22 mutations
    Kim, Jee Young
    Koo, Haesoo
    Park, Kee-Duk
    Choi, Sun Sung
    Yu, Jin Seok
    Hong, Young Bin
    Chung, Ki Wha
    Choi, Byung-Ok
    GENES & GENOMICS, 2016, 38 (07) : 659 - 667
  • [37] INVESTIGATION OF SENSORS TO IDENTIFY GAIT BIOMARKERS IN INDIVIDUALS WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A)
    Baker, Lindsay
    Dinesh, Karthik
    Sowden, Janet
    Behrens-Spraggins, Steffen
    Charles, Julie
    Wood, Elizabeth
    Sharma, Gaurav
    Herrmann, David
    Eichinger, Katy
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S12 - S13
  • [38] TRISOMY-17P ASSOCIATED WITH CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1A PHENOTYPE - EVIDENCE FOR GENE DOSAGE AS A MECHANISM IN CMT1A
    CHANCE, PF
    BIRD, TD
    MATSUNAMI, N
    LENSCH, MW
    BROTHMAN, AR
    FELDMAN, GM
    NEUROLOGY, 1992, 42 (12) : 2295 - 2299
  • [39] GENE DOSAGE IS A MECHANISM FOR CHARCOT-MARIE-TOOTH DISEASE TYPE-1A
    LUPSKI, JR
    WISE, CA
    KUWANO, A
    PENTAO, L
    PARKE, JT
    GLAZE, DG
    LEDBETTER, DH
    GREENBERG, F
    PATEL, PI
    NATURE GENETICS, 1992, 1 (01) : 29 - 33
  • [40] Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future
    Boutary, Suzan
    Echaniz-Laguna, Andoni
    Adams, David
    Loisel-Duwattez, Julien
    Schumacher, Michael
    Massaad, Charbel
    Massaad-Massade, Liliane
    TRANSLATIONAL RESEARCH, 2021, 227 : 100 - 111
12345